Journal
Rychert, M., & Wilkins, C. (2019). A ‘community enterprise’ model for recreational cannabis: Lessons from alcohol licensing trusts in New Zealand.
International Journal of Drug Policy. 67, 72-78
[Journal article]Authored by: Rychert, M., Wilkins, C.Read Online:
Read Abstract:
Rychert, M., & Wilkins, C. (2019). New Zealand's review of the Psychoactive Substances Act 2013: a missed learning opportunity ahead of the national cannabis law reform referendum?.
Addiction. 114(6), 1129-1130
[Journal article]Authored by: Rychert, M., Wilkins, C.Read Online:
Wilkins, C., Rychert, M., Romeo, JS., & Randerson, S. (2019). Smoke in our eyes: The sense partners’ evaluation of the legalisation of cannabis in New Zealand.
New Zealand Medical Journal. 132(1490), 6-9
[Journal article]Authored by: Romeo Nunez, J., Rychert, M., Wilkins, C.Moore, JS., Forster, C., Diesfeld, K., & Rychert, M. (2018). New Zealand lawyers and conveyancers disciplinary tribunal cases involving vulnerable clients, 2011–2017<sup>*</sup>.
International Journal of the Legal Profession.
[Journal article]Authored by: Rychert, M.Read Online:
Read Abstract:
Wilkins, C., Romeo, JS., Rychert, M., Prasad, J., & Graydon-Guy, T. (2018). Determinants of high availability of methamphetamine, cannabis, LSD and ecstasy in New Zealand: Are drug dealers promoting methamphetamine rather than cannabis?.
International Journal of Drug Policy. 61, 15-22
[Journal article]Authored by: Romeo Nunez, J., Rychert, M., Wilkins, C.Read Online:
Read Abstract:
view more...
Wilkins, C., & Rychert, M. (2018). Responding to a new wave of high potency synthetic cannabinoids.
New Zealand Medical Journal. 131(1482), 6-9
[Journal article]Authored by: Rychert, M., Wilkins, C.Rychert, M. (2018). New Zealand court dismisses Ministry of Health case against ‘heat-not-burn’ tobacco products, highlighting the need to future-proof tobacco control laws.
Addiction. 113(10), 1953-1954
[Journal article]Authored by: Rychert, M.Read Online:
Rychert, M., & Wilkins, C. (2018). Understanding the development of a regulated market approach to new psychoactive substances (NPS) in New Zealand using Punctuated Equilibrium Theory.
Addiction. 113(11), 2132-2139
[Journal article]Authored by: Rychert, M., Wilkins, C.Read Online:
Read Abstract:
Rychert, M., & Wilkins, C. (2018). A critical analysis of the implementation of a legal regulated market for new psychoactive substances (“legal highs”) in New Zealand.
International Journal of Drug Policy. 55, 88-94
[Journal article]Authored by: Rychert, M., Wilkins, C.Read Online:
Read Abstract:
Rychert, M., Wilkins, C., Parker, K., & Witten, K. (2018). Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand.
Drug and Alcohol Review. 37(3), 406-413
[Journal article]Authored by: Parker, K., Rychert, M., Wilkins, C., Witten, K.Read Online:
Read Abstract:
Rychert, M. (2017). New Zealand’s legal action against IQOS postponed, consultation with big tobacco follows.
New Zealand Medical Journal. 130(1465), 109-111
[Journal article]Authored by: Rychert, M.Wilkins, C., Prasad, J., Parker, K., Rychert, M., & Barnes, HM. (2017). Recent Trends in Alcohol and Other Drug Use Among Police Detainees in New Zealand, 2010-2015.
Current topics in behavioral neurosciences. 34, 161-172
[Journal article]Authored by: Parker, K., Rychert, M., Wilkins, C.Read Online:
Read Abstract:
Rychert, M., Wilkins, C., & Witten, K. (2017). Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances (‘legal highs’) in New Zealand.
Drug and Alcohol Review. 36(5), 589-596
[Journal article]Authored by: Rychert, M., Wilkins, C., Witten, K.Read Online:
Read Abstract:
Rychert, M., Wilkins, C., & Witten, K. (2017). “Lost in translation”: Issues with the establishment of a legal market for “low risk” psychoactive products (“legal highs”) in New Zealand.
Drugs: Education, Prevention and Policy. , 1-8
[Journal article]Authored by: Rychert, M., Wilkins, C., Witten, K.Read Online:
Read Abstract:
Rychert, M., & Wilkins, C. (2017). Thirty-one psychoactive plants exempted from New Zealand's Psychoactive Substances Act 2013.
Addiction. 112(1), 181-182
[Journal article]Authored by: Rychert, M., Wilkins, C.Read Online:
Wilkins, C., & Rychert, M. (2017). Recent developments with the New Zealand regulated market approach to ‘low-risk’ psychoactive products.
Addiction. 112(1), 34-36
[Journal article]Authored by: Rychert, M., Wilkins, C.Read Online:
Rychert, M., & Wilkins, C. (2016). Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, ‘legal highs’) in New Zealand.
International Journal of Drug Policy. 37, 90-97
[Journal article]Authored by: Rychert, M., Wilkins, C.Read Online:
Read Abstract:
Wilkins, C., Prasad, J., Wong, KC., Graydon-Guy, T., & Rychert, M. (2016). An exploratory study of the health harms and utilisation of health services of frequent legal high users under the interim regulated legal high market in central Auckland.
New Zealand Medical Journal. 129(1431), 51-58
[Journal article]Authored by: Rychert, M., Wilkins, C.Read Abstract:
Rychert, M., & Wilkins, C. (2016). What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, ‘legal highs’)? Implications for law enforcement and penalties.
Drug Testing and Analysis. 8(8), 768-778
[Journal article]Authored by: Rychert, M., Wilkins, C.Read Online:
Read Abstract:
Rychert, M., & Wilkins, C. (2015). Did we have the wrong debate about elixinol<sup>™</sup>and medicinal cannabis?.
New Zealand Medical Journal. 128(1421), 69-70
[Journal article]Authored by: Rychert, M., Wilkins, C.Rychert, M., & Wilkins, C. (2015). The challenge of a ban on animal testing for the development of a regulated legal market for new psychoactive substances (NPS) ('legal highs') in New Zealand: Issues and options for resolution.
International Journal of Drug Policy. 26(12), 1273-1278
[Journal article]Authored by: Rychert, M., Wilkins, C.Read Online:
Read Abstract:
Rychert, M., & Wilkins, C. (2015). Is the recent ban on animal testing of legal high products a fatal blow to the development of a legal market for 'low-risk' psychoactive products in New Zealand?.
Addiction. 110(4), 714-715
[Journal article]Authored by: Rychert, M., Wilkins, C.Read Online:
view less...
Book
Wilkins, ., Prasad, ., Moewaka Barnes, H., Romeo, JS., & Rychert, . (2017).
New Zealand Arrestee Drug Use Monitoring (NZ-ADUM) 2016 Report. : Massey University
[Monograph]Authored by: Moewaka Barnes, H., Romeo Nunez, J., Rychert, M., Wilkins, C.Wilkins, C., Prasad, J., Romeo, JS., & Rychert, . (2017).
Recent trends in illegal drug use in New Zealand, 2006-2016: Findings from the Illicit Drug Monitoring System (IDMS). : Massey University
[Monograph]Authored by: Romeo Nunez, J., Rychert, M., Wilkins, C.Wilkins, C., Rychert, M., Byrska, B., Van Hout, MC., Corazza, O., & Roman-Urrestarazu, A. (2017). Exploring innovative policy responses to NPS and legal highs
in New Zealand, Poland, Republic of Ireland and the UK. In O. Corazza, & A. Roman-Urrestarazu (Eds.)
Novel Psychoactive Substances. Policy, Economics and Drug Regulation. (pp. 57 - 74). Cham, Switzerland: Springer Nature
[Chapter]Authored by: Rychert, M., Wilkins, C.Read Online:
Read Abstract:
Rychert, M., & Wilkins, C. (2017). New Zealand’s pre-market approval regime for low risk new psychoactive substances (NPS, legal highs) – a regulatory alternative to prohibition. In A. Malczewski (Ed.)
Monitoring and response to Drugs, Drug Addiction and New Psychoactive Substances (English title) / Monitorowanie problemu narkotyków i narkomanii na poziomie lokalnym oraz przeciwdziałanie narkotykom i „dopalaczom” (Title in Polish). (pp. 171 - 182). Warsaw, Poland: Information Center for Drugs and Drug Addiction
[Chapter]Authored by: Rychert, M., Wilkins, C.Read Abstract:
Report
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), .(2014).
EMCDDA–Europol joint report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone). Luxembourg: Publications Office of the European Union
[Technical Report]Contributed to by: Rychert, M.Read Online:
Read Abstract:
Mounteney, J., Groshkova, T., Thanki, D., Cunningham, A., & Rychert, M.(2014).
Exploring methamphetamine trends in Europe. Luxembourg: Publications Office of the European Union
[Technical Report]Authored by: Rychert, M.Contributed to by: Rychert, M.Read Online:
Read Abstract:
Rychert, M., Palczak, K., Zobel, F., & Hughes, B.(2014).
Drug policy profile: Poland. Luxembourg: Publications Office of the European Union
[Technical Report]Authored by: Rychert, M.Read Online:
Read Abstract:
